Breaking News Instant updates and real-time market news.

RPAY

Repay Holdings

$20.63 /

-0.48 (-2.27%)

18:37
05/28/20
05/28
18:37
05/28/20
18:37

Repay Holdings 8M share Secondary priced at $20.00

The deal priced below the last closing price of $20.62. Morgan Stanley, Credit Suisse and Barclays are acting as joint book running managers for the offering.

  • 29

    May

RPAY Repay Holdings
$20.63 /

-0.48 (-2.27%)

05/19/20 BTIG
Repay Holdings price target raised to $25 from $20 at BTIG
04/17/20
Fly Intel: Top five analyst initiations
04/17/20 DA Davidson
Repay Holdings initiated with a Buy at DA Davidson
03/17/20 Canaccord
Repay Holdings outlook could be helped by current environment, says Canaccord

TODAY'S FREE FLY STORIES

Initiation
Jones Lang LaSalle initiated with a Buy at Goldman Sachs » 04:56
01/25/21
01/25
04:56
01/25/21
04:56
JLL

Jones Lang LaSalle

$159.86 /

+5.25 (+3.40%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JLL Jones Lang LaSalle
$159.86 /

+5.25 (+3.40%)

JLL Jones Lang LaSalle
$159.86 /

+5.25 (+3.40%)

12/21/20 JPMorgan
Jones Lang LaSalle price target raised to $172 from $132 at JPMorgan
10/07/20 Keefe Bruyette
Jones Lang LaSalle downgraded to Market Perform at Keefe Bruyette
10/07/20 Keefe Bruyette
Jones Lang LaSalle downgraded to Market Perform from Outperform at Keefe Bruyette
04/09/20 JPMorgan
Cushman & Wakefield downgraded to Neutral as 'riskiest' CRE broker at JPMorgan
JLL Jones Lang LaSalle
$159.86 /

+5.25 (+3.40%)

Initiation
CBRE Group initiated with a Buy at Goldman Sachs » 04:55
01/25/21
01/25
04:55
01/25/21
04:55
CBRE

CBRE Group

$65.99 /

+0.96 (+1.48%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CBRE CBRE Group
$65.99 /

+0.96 (+1.48%)

CBRE CBRE Group
$65.99 /

+0.96 (+1.48%)

12/21/20 JPMorgan
CBRE Group price target raised to $65 from $52 at JPMorgan
04/09/20 JPMorgan
Cushman & Wakefield downgraded to Neutral as 'riskiest' CRE broker at JPMorgan
04/09/20 JPMorgan
CBRE Group downgraded to Neutral on valuation at JPMorgan
04/09/20 JPMorgan
CBRE Group downgraded to Neutral from Overweight at JPMorgan
CBRE CBRE Group
$65.99 /

+0.96 (+1.48%)

General news
6-Month Bill Auction to be released at 11:30  04:55
01/25/21
01/25
04:55
01/25/21
04:55
 
Conference/Events
Stephens specialty finance analyst to hold analyst/industry conference call » 04:55
01/25/21
01/25
04:55
01/25/21
04:55

Specialty Finance Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
FedEx management to meet virtually with Oppenheimer » 04:55
01/25/21
01/25
04:55
01/25/21
04:55
FDX

FedEx

$254.00 /

+0.06 (+0.02%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$254.00 /

+0.06 (+0.02%)

FDX FedEx
$254.00 /

+0.06 (+0.02%)

01/07/21 Wolfe Research
FedEx downgraded to Peer Perform from Outperform at Wolfe Research
12/30/20 Argus
FedEx price target raised to $305 from $270 at Argus
12/18/20 Raymond James
FedEx price target raised to $305 from $280 at Raymond James
12/18/20 Morgan Stanley
FedEx's 'modest' Q2 beat likely falls short of high bar, says Morgan Stanley
FDX FedEx
$254.00 /

+0.06 (+0.02%)

FDX FedEx
$254.00 /

+0.06 (+0.02%)

FDX FedEx
$254.00 /

+0.06 (+0.02%)

FDX FedEx
$254.00 /

+0.06 (+0.02%)

General news
3-Month Bill Auction to be released at 11:30  04:55
01/25/21
01/25
04:55
01/25/21
04:55
 
General news
3-Month Bill Auction to be released at 11:30  04:55
01/25/21
01/25
04:55
01/25/21
04:55
 
Conference/Events
Seelos Therapeutics management to meet virtually with Roth Capital » 04:55
01/25/21
01/25
04:55
01/25/21
04:55
SEEL

Seelos Therapeutics

$2.58 /

+0.47 (+22.27%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SEEL Seelos Therapeutics
$2.58 /

+0.47 (+22.27%)

SEEL Seelos Therapeutics
$2.58 /

+0.47 (+22.27%)

09/09/20 Roth Capital
Seelos Therapeutics shares 'substantially undervalued,' says Roth Capital
06/23/20 Roth Capital
Seelos Therapeutics price target raised to $12 from $8 Roth Capital
  • 12
    Mar
  • 11
    Feb
Conference/Events
Navidea management to meet virtually with Oppenheimer » 04:55
01/25/21
01/25
04:55
01/25/21
04:55
NAVB

Navidea

$2.27 /

+0.025 (+1.12%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NAVB Navidea
$2.27 /

+0.025 (+1.12%)

NAVB Navidea
$2.27 /

+0.025 (+1.12%)

08/17/20 H.C. Wainwright
Navidea price target raised to $8 from $6 at H.C. Wainwright
05/22/20 H.C. Wainwright
Navidea price target raised to $6 from $4 at H.C. Wainwright
NAVB Navidea
$2.27 /

+0.025 (+1.12%)

NAVB Navidea
$2.27 /

+0.025 (+1.12%)

Conference/Events
Newborn Acquisition Corp. management to meet virtually with Roth Capital » 04:55
01/25/21
01/25
04:55
01/25/21
04:55
NBAC

Newborn Acquisition Corp.

$17.65 /

-0.29 (-1.62%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NBAC Newborn Acquisition Corp.
$17.65 /

-0.29 (-1.62%)

General news
6-Month Bill Auction to be released at 11:30  04:55
01/25/21
01/25
04:55
01/25/21
04:55
 
Conference/Events
U.S. Bancorp management to meet virtually with Evercore ISI » 04:55
01/25/21
01/25
04:55
01/25/21
04:55
USB

U.S. Bancorp

$45.86 /

+0.2 (+0.44%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
USB U.S. Bancorp
$45.86 /

+0.2 (+0.44%)

USB U.S. Bancorp
$45.86 /

+0.2 (+0.44%)

01/22/21
Fly Intel: Top five analyst upgrades
01/22/21 Citi
U.S. Bancorp upgraded to Buy from Neutral at Citi
01/07/21 Jefferies
U.S. Bancorp upgraded to Buy with $58 price target at Jefferies
01/07/21 BofA
U.S. Bancorp downgraded to Underperform from Neutral at BofA
USB U.S. Bancorp
$45.86 /

+0.2 (+0.44%)

USB U.S. Bancorp
$45.86 /

+0.2 (+0.44%)

USB U.S. Bancorp
$45.86 /

+0.2 (+0.44%)

USB U.S. Bancorp
$45.86 /

+0.2 (+0.44%)

Recommendations
Cinemark price target raised to $16 from $11 at Goldman Sachs » 04:52
01/25/21
01/25
04:52
01/25/21
04:52
CNK

Cinemark

$19.55 /

+0.97 (+5.22%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNK Cinemark
$19.55 /

+0.97 (+5.22%)

CNK Cinemark
$19.55 /

+0.97 (+5.22%)

01/15/21 B. Riley Securities
B. Riley upgrades Cinemark, doubles target ahead of theater return
01/15/21 MoffettNathanson
Cinemark price target raised to $14 from $12 at MoffettNathanson
01/15/21 B. Riley Securities
Cinemark upgraded to Buy from Neutral at B. Riley Securities
12/28/20 B. Riley Securities
'Wonder Women' opens well above expectations, says B. Riley Securities
CNK Cinemark
$19.55 /

+0.97 (+5.22%)

CNK Cinemark
$19.55 /

+0.97 (+5.22%)

CNK Cinemark
$19.55 /

+0.97 (+5.22%)

CNK Cinemark
$19.55 /

+0.97 (+5.22%)

Downgrade
Imax downgraded to Neutral from Buy at Goldman Sachs » 04:51
01/25/21
01/25
04:51
01/25/21
04:51
IMAX

Imax

$18.49 /

+0.17 (+0.93%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMAX Imax
$18.49 /

+0.17 (+0.93%)

IMAX Imax
$18.49 /

+0.17 (+0.93%)

01/06/21 Barrington
Imax and Sirius XM among Barrington's best ideas for 2021
12/29/20 B. Riley Securities
Imax price target raised to $26 from $18 at B. Riley Securities
12/28/20 B. Riley Securities
'Wonder Women' opens well above expectations, says B. Riley Securities
12/21/20 B. Riley Securities
Imax positioned for box office upside, says B. Riley Securities
IMAX Imax
$18.49 /

+0.17 (+0.93%)

IMAX Imax
$18.49 /

+0.17 (+0.93%)

IMAX Imax
$18.49 /

+0.17 (+0.93%)

IMAX Imax
$18.49 /

+0.17 (+0.93%)

Recommendations
Cars.com price target raised to $12.50 from $9.50 at Goldman Sachs » 04:49
01/25/21
01/25
04:49
01/25/21
04:49
CARS

Cars.com

$13.59 /

+0.12 (+0.89%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CARS Cars.com
$13.59 /

+0.12 (+0.89%)

CARS Cars.com
$13.59 /

+0.12 (+0.89%)

11/10/20 Citi
Cars.com price target raised to $10.50 from $9 at Citi
10/15/20
Fly Intel: Top five analyst upgrades
10/15/20 Craig-Hallum
Cars.com upgraded to Buy at Craig-Hallum
10/15/20 Craig-Hallum
Cars.com upgraded to Buy from Hold at Craig-Hallum
CARS Cars.com
$13.59 /

+0.12 (+0.89%)

CARS Cars.com
$13.59 /

+0.12 (+0.89%)

Recommendations
CarGurus price target raised to $40 from $33 at Goldman Sachs » 04:48
01/25/21
01/25
04:48
01/25/21
04:48
CARG

CarGurus

$31.43 /

-0.43 (-1.35%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CARG CarGurus
$31.43 /

-0.43 (-1.35%)

CARG CarGurus
$31.43 /

-0.43 (-1.35%)

12/14/20 BTIG
CarGurus price target raised to $34 from $28 at BTIG
12/11/20 DA Davidson
CarGurus found 'compelling' asset in CarOffer, says DA Davidson
12/10/20 Benchmark
CarGurus' deal for CarOffer increases Benchmark's 'optimistic view'
12/04/20 Jefferies
CarGurus initiated with a Hold at Jefferies
CARG CarGurus
$31.43 /

-0.43 (-1.35%)

CARG CarGurus
$31.43 /

-0.43 (-1.35%)

Initiation
TrueCar reinstated with a Neutral at Goldman Sachs » 04:47
01/25/21
01/25
04:47
01/25/21
04:47
TRUE

TrueCar

$5.04 /

+0.18 (+3.70%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRUE TrueCar
$5.04 /

+0.18 (+3.70%)

TRUE TrueCar
$5.04 /

+0.18 (+3.70%)

11/20/20 Needham
Ford launch an 'interesting response' to auto retailing shift, says Needham
11/11/20 Truist
TrueCar price target lowered to $4.50 from $6 at Truist
11/09/20
Fly Intel: Top five analyst upgrades
11/09/20 Citi
TrueCar price target lowered to $4.50 from $5.50 at Citi
TRUE TrueCar
$5.04 /

+0.18 (+3.70%)

TRUE TrueCar
$5.04 /

+0.18 (+3.70%)

TRUE TrueCar
$5.04 /

+0.18 (+3.70%)

Recommendations
VF Corp. price target raised to $86 from $76 at Pivotal Research » 04:46
01/25/21
01/25
04:46
01/25/21
04:46
VFC

VF Corp.

$83.87 /

-0.32 (-0.38%)

Pivotal Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VFC VF Corp.
$83.87 /

-0.32 (-0.38%)

VFC VF Corp.
$83.87 /

-0.32 (-0.38%)

01/22/21 Williams Capital
VF Corp. initiated with a Buy at Williams Trading
01/21/21 Deutsche Bank
VF Corp. upgraded to Buy from Hold at Deutsche Bank
01/21/21 Deutsche Bank
VF Corp. upgraded to Buy from Hold at Deutsche Bank
01/11/21 OTR Global
VF Corp. upgraded to Positive from Mixed at OTR Global
VFC VF Corp.
$83.87 /

-0.32 (-0.38%)

VFC VF Corp.
$83.87 /

-0.32 (-0.38%)

VFC VF Corp.
$83.87 /

-0.32 (-0.38%)

VFC VF Corp.
$83.87 /

-0.32 (-0.38%)

Upgrade
Medifast upgraded to Buy from Hold at Jefferies » 04:44
01/25/21
01/25
04:44
01/25/21
04:44
MED

Medifast

$220.75 /

-0.7 (-0.32%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MED Medifast
$220.75 /

-0.7 (-0.32%)

MED Medifast
$220.75 /

-0.7 (-0.32%)

01/12/21 DA Davidson
Medifast price target raised to $239 from $205 at DA Davidson
11/05/20 DA Davidson
Medifast upgraded to Buy from Neutral at DA Davidson
11/03/20 B. Riley Securities
Medifast price target raised to $250 from $230 at B. Riley Securities
10/09/20 B. Riley Securities
Medifast price target raised to $230 from $220 at B. Riley Securities
MED Medifast
$220.75 /

-0.7 (-0.32%)

MED Medifast
$220.75 /

-0.7 (-0.32%)

Upgrade
Atlantic Capital upgraded to Outperform from Market Perform at Raymond James » 04:42
01/25/21
01/25
04:42
01/25/21
04:42
ACBI

Atlantic Capital

$17.51 /

+0.48 (+2.82%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACBI Atlantic Capital
$17.51 /

+0.48 (+2.82%)

General news
FX Action: USD-CAD has corrected some of the gains » 03:45
01/25/21
01/25
03:45
01/25/21
03:45

FX Action: USD-CAD has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Update: The dollar is modestly lower » 03:30
01/25/21
01/25
03:30
01/25/21
03:30

FX Update: The dollar is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Asian Market Update: » 03:05
01/25/21
01/25
03:05
01/25/21
03:05

Asian Market Update: Risk…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
U.S. Dallas Fed preview » 03:05
01/25/21
01/25
03:05
01/25/21
03:05

U.S. Dallas Fed preview:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Magnite downgraded to Hold from Buy at Truist » 20:51
01/24/21
01/24
20:51
01/24/21
20:51
MGNI

Magnite

$40.09 /

+3.725 (+10.24%)

Truist analyst Matthew…

Truist analyst Matthew Thornton downgraded Magnite to Hold from Buy with a price target of $37, up from $12. The analyst cites valuation for the downgrade, seeing a balanced risk/reward at current share a levels. Further, he believes lower reported growth in the second half of 2021 "could be a headwind." Magnite's revenue growth could slow to 12% in the second half from 60% from the first half as it lapses the Telaria merger and easy Q2 Covid-compares, Thornton tells investors in a research note.

ShowHide Related Items >><<
MGNI Magnite
$40.09 /

+3.725 (+10.24%)

MGNI Magnite
$40.09 /

+3.725 (+10.24%)

01/22/21 Craig-Hallum
Magnite price target raised to $45 from $25 at Craig-Hallum
01/11/21 Susquehanna
Magnite weakness a buying opportunity, says Susquehanna
12/21/20 Needham
Magnite price target raised to $30 from $18 at Needham
12/18/20 Susquehanna
Susquehanna starts top SSP company Magnite with Positive rating
MGNI Magnite
$40.09 /

+3.725 (+10.24%)

MGNI Magnite
$40.09 /

+3.725 (+10.24%)

MGNI Magnite
$40.09 /

+3.725 (+10.24%)

MGNI Magnite
$40.09 /

+3.725 (+10.24%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.